Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma
- Status
- UNKNOWN
- Phase
- PHASE2
Determine if Either of 2 Doses of Study Drug Given With a Low-dose of Cyclophosphamide After a Complete or Partial Response to a Platinum-based Second-line Therapy in Women With Recurrent Ovarian Carcinoma Results in a Longer Time to Progression When Compared to the First Time to Progression.
- Status
- WITHDRAWN
- Phase
- PHASE2
Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab Study With Carboplatin & Paclitaxel in Ovarian, Fallopian Tube or Primary Peritoneal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Enzastaurin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
MITO-6: Capecitabine in Platinum Resistant Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
MITO-5: Weekly Carboplatin and Paclitaxel as First Line Chemotherapy for Elderly Patients With Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy Study of Panzem® Nanocrystal Colloidal Dispersion in Patients With Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo ("Sugar Pill")
- Status
- COMPLETED
- Phase
- PHASE2
Paclitaxel and Carboplatin With Or Without Sorafenib In The First-Line Treatment Of Patients With Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Improving Employment in Patients Who Have Survived Cervical Cancer, Uterine Cancer, or Ovarian Cancer
- Status
- COMPLETED
- Phase
- NA
OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Vaccine Therapy, Paclitaxel, and Carboplatin in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Responded to Previous Cisplatin or Carboplatin
- Status
- WITHDRAWN
- Phase
- PHASE2
Validation of a Score of Predictive Factors for Complete Resection in Platinum-sensitive Recurrent Ovarian Cancer
- Status
- COMPLETED
- Phase
- N/A
Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer
- Status
- TERMINATED
- Phase
- PHASE2